Search - tctmd.com

Displaying 561 - 571 of 571

Presentation TCT 2012

Impact of Renal Impairment on Clinical and Angiographic Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents: a Pooled Analysis of SIRTAX, LEADERS, and...

Presenter: Giulio G. Stefanini, Bindu Kalesan, Lorenz Raber, Thomas Pilgrim, Yoshinobu Onuma, Sigmund Silber, Patrick W. Serruys, Bernhard Meier, Peter Juni, Stephan Windecker

January 03, 2012

Presentation TCT 2012

Impact of Peristent Plaque Change after Drug-Eluting Stents Implantation -Comparison between Zotarolimus-Eluting Stents and Paclitaxel-Eluting Stents-

Presenter: Yoshitaka Muraoka, Shinjo Sonoda, Kuninobu Kashiyama, Reo Anai, Fumihiko Kamezaki, Yuki Tsuda, Masaru Araki, Masahiro Okazaki, Yutaka Otsuji

January 03, 2012

Presentation TCT 2012

Impact of ApoB/ApoA-I ratio on two-year Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention with Drug-eluting Stents

Presenter: Sang-Ho Park, Seung Woon Rha, Jae Yun Kim, A-Ra Cho, Hyeok-Gyu Lee, Se-Whan Lee, Won-Yong Shin, Seung-Jin Lee, Dong-Kyu Jin, Byoung Geol Choi, Amro Elnagar, Sung Il Im, SunWon Kim, Jin Oh Na, Seong Woo Han, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh

January 03, 2012

Presentation TCT 2012

Frequency and Predictors of Drug Eluting Stents Implantation in Patients with Acute Myocardial Infarction - Analysis from the PL-ACS Registry.

Presenter: Marek Gierlotka, Mariusz Gasior, Michal Hawranek, Zbigniew Kalarus, Pawel Buszman, Jacek Legutko, Andrzej Lekston, Lech Polonski

January 03, 2012

Presentation TCT 2012

Five Year Survival After Percutaneous Coronary Intervention With Drug Eluting Stents And Bare Metal Stents In All-Comers. A New Jersey Statewide Database Study

Presenter: Tudor Vagaonescu, Abel E. Moreyra, Yingzi Deng, Nora Cosgrove, John B. Kostis

January 03, 2012

Presentation TCT 2012

First Generation versus Newer Generation Drug-eluting Stents in Unprotected Left Main Coronary Artery Intervention

Presenter: Amro Elnagar, Seung Woon Rha, Byoung Geol Choi, Sung Il Im, SunWon Kim, Jin Oh Na Na, Seong Woo Han, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh

January 03, 2012

Presentation TCT 2012

Drug Eluting Stents in the Treatment of Isolated Proximal LAD Disease are Associated with Similar Outcomes Compared to Minimally Invasive LIMA Grafts

Presenter: Daniel A. Jones, Krishnaraj S. Rathod, Sean M. Gallagher, Zia Buckhoree, Mohammed Akhtar, Ajay K. Jain, Charles Knight, Anthony Mathur, Rakesh Uppal, Andrew Wragg

January 03, 2012

Presentation TCT 2012

Does Diabetes Mellitus Impact on Clinical Outcomes following Chronic Total Occlusion Intervention with Drug-eluting Stents?

Presenter: Amro Elnagar, Seung Woon Rha, Byoung Geol Choi, Sung Il Im, SunWon Kim, Jin Oh Na, Seong Woo Han, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh

January 03, 2012

Presentation TCT 2012

Correction of Anemia During Follow Up Periods Improves Clinical Outcomes In Patients Who Underwent Drug Eluting Stents

Presenter: Pum-Joon Kim, Tae-Hoon Kim, Kiyuk Chang, Yoon-Seok Koh, Suk-Min Seo, Chan-Joon Kim, Hun-Jun Park, Jong Min Lee, Wook-Sung Chung, Ki-Bae Seung

January 03, 2012

Presentation TCT 2012

Clinical Outcome in Diabetic Patients Treated for Coronary Bifurcation Lesions by Drug Eluting Stents - Pooled Analysis of the BBC ONE study and the Nordic Bifurcation Studies.

Presenter: Michael Maeng, David Hildick-Smith, Niels R. Holm, Adam de Belder, Matti Niemela, Nicholaus P. Curzen, Kari Kervinen, Andrejs Erglis, Indulis Kumsars, Keith G. Oldroyd, Paal Gunnes, Rodney H. Stables, Terje Steigen, Miles Behan, Jens F. Lassen, Leif Thuesen

January 03, 2012

Presentation TCT 2012

”Safety of Dual Antiplatelet Therapy in Patients Treated with Coronary Drug Eluting Stents.”

Presenter: Andrzej Drewnicki, Maciej Lesiak, Malgorzata Pyda, Marek Grygier, Wlodzimierz Skorupski, Aleksander Araszkiewicz, Przemyslaw Mitkowski, Stefan Grajek

January 03, 2012

Advertisement

Impact of Renal Impairment on Clinical and Angiographic Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents: a Pooled Analysis of SIRTAX, LEADERS, and...

Impact of Peristent Plaque Change after Drug-Eluting Stents Implantation -Comparison between Zotarolimus-Eluting Stents and Paclitaxel-Eluting Stents-

Impact of ApoB/ApoA-I ratio on two-year Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention with Drug-eluting Stents

Frequency and Predictors of Drug Eluting Stents Implantation in Patients with Acute Myocardial Infarction - Analysis from the PL-ACS Registry.

Five Year Survival After Percutaneous Coronary Intervention With Drug Eluting Stents And Bare Metal Stents In All-Comers. A New Jersey Statewide Database Study

First Generation versus Newer Generation Drug-eluting Stents in Unprotected Left Main Coronary Artery Intervention

Drug Eluting Stents in the Treatment of Isolated Proximal LAD Disease are Associated with Similar Outcomes Compared to Minimally Invasive LIMA Grafts

Does Diabetes Mellitus Impact on Clinical Outcomes following Chronic Total Occlusion Intervention with Drug-eluting Stents?

Correction of Anemia During Follow Up Periods Improves Clinical Outcomes In Patients Who Underwent Drug Eluting Stents

Clinical Outcome in Diabetic Patients Treated for Coronary Bifurcation Lesions by Drug Eluting Stents - Pooled Analysis of the BBC ONE study and the Nordic Bifurcation Studies.

”Safety of Dual Antiplatelet Therapy in Patients Treated with Coronary Drug Eluting Stents.”

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content